APOA2 and pachyonychia congenita: Recent research has indicated that alterations in apoA2-ATQ/AT concentrations due to abnormal amino acid processing at the C-terminal end of the apoA2 homodimer can help in distinguishing patients with early-stage PC from healthy individuals [10,11,12,13].